Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wilschanski

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Expert Opinion on Investigational Drugs|July 13, 2011
New drugs for cystic fibrosisMichael Wilschanski, Eitan Kerem
The Israel Medical Association Journal : IMAJ|December 17, 2008
Novel therapeutic modalities in pediatric inflammatory bowel diseaseEyal Shteyer, Michael Wilschanski
Frontline Gastroenterology|December 17, 2021
Cystic fibrosis and the gutMordechai Slae, Michael Wilschanski
Drug Design, Development and Therapy|July 13, 2012
Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapiesDaina Kalnins, Michael Wilschanski
Current Opinion in Pulmonary Medicine|October 1, 2019
Prevention of malnutrition in cystic fibrosisMordechai Slae, Michael Wilschanski
Cold Spring Harbor Perspectives in Medicine|May 3, 2013
The cystic fibrosis of exocrine pancreasMichael Wilschanski, Ivana Novak
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 8, 2017
IntroductionSteven D Freedman, Michael Wilschanski
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 10, 2026
GI and liver updates in CF: The next frontierSteven D Freedman, Michael Wilschanski
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 28, 2021
Cystic Fibrosis Related Gastrointestinal Manifestations - Moving ForwardLiron Birimberg-Schwartz, Michael Wilschanski
Gut|April 21, 2007
Patterns of GI disease in adulthood associated with mutations in the CFTR geneMichael Wilschanski, Peter R Durie
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Expert Opinion on Investigational Drugs|July 13, 2011
New drugs for cystic fibrosisMichael Wilschanski, Eitan Kerem
The Israel Medical Association Journal : IMAJ|December 17, 2008
Novel therapeutic modalities in pediatric inflammatory bowel diseaseEyal Shteyer, Michael Wilschanski
Frontline Gastroenterology|December 17, 2021
Cystic fibrosis and the gutMordechai Slae, Michael Wilschanski
Drug Design, Development and Therapy|July 13, 2012
Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapiesDaina Kalnins, Michael Wilschanski
Current Opinion in Pulmonary Medicine|October 1, 2019
Prevention of malnutrition in cystic fibrosisMordechai Slae, Michael Wilschanski
Cold Spring Harbor Perspectives in Medicine|May 3, 2013
The cystic fibrosis of exocrine pancreasMichael Wilschanski, Ivana Novak
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 8, 2017
IntroductionSteven D Freedman, Michael Wilschanski
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 10, 2026
GI and liver updates in CF: The next frontierSteven D Freedman, Michael Wilschanski
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 28, 2021
Cystic Fibrosis Related Gastrointestinal Manifestations - Moving ForwardLiron Birimberg-Schwartz, Michael Wilschanski
Gut|April 21, 2007
Patterns of GI disease in adulthood associated with mutations in the CFTR geneMichael Wilschanski, Peter R Durie
Pageof 16